These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 408896)

  • 1. [Experimental study on the resistance of a strain of Trypanosoma cruzi to Bay 2502].
    Andrade SG; Andrade ZA; Figueira RM
    Rev Inst Med Trop Sao Paulo; 1977; 19(2):124-9. PubMed ID: 408896
    [No Abstract]   [Full Text] [Related]  

  • 2. Animal experimental investigation into the activity of nifurtimox against Trypanosoma cruzi.
    Haberkorn A; Gönnert R
    Arzneimittelforschung; 1972 Sep; 22(9):1570-82. PubMed ID: 4630483
    [No Abstract]   [Full Text] [Related]  

  • 3. [Reaction of the Trypanosoma cruzi strain to the experimental therapeutical response to Bay 2502 (results of long term treatment)].
    Andrade SG; Figueira RM; Carvalho ML; Gorini DF
    Rev Inst Med Trop Sao Paulo; 1975; 17(6):380-9. PubMed ID: 815983
    [No Abstract]   [Full Text] [Related]  

  • 4. [Etiological treatment of Chagas' disease].
    Rassi A
    Arq Bras Cardiol; 1982 Apr; 38(4):277-81. PubMed ID: 6820273
    [No Abstract]   [Full Text] [Related]  

  • 5. [Action of nitrofurazone (5-nitro-2-furaldehyde-semicarbazone) on the intracellular forms of Trypanosoma intracellular forms of Trypanosoma cruzi in experimental Chagas' disease].
    Andrade ZA; Brener Z
    Rev Inst Med Trop Sao Paulo; 1969; 11(3):222-8. PubMed ID: 4980992
    [No Abstract]   [Full Text] [Related]  

  • 6. [In vivo and in vitro susceptibility of Trypanosoma cruzi to ketoconazole].
    Rubiolo ER; Cano RC
    Rev Latinoam Microbiol; 1987; 29(4):395-401. PubMed ID: 3149794
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experimental study on the therapeutic action of Ro 7-1051 on infections caused by different strains of Trypanosoma cruzi].
    Andrade SG; Figueira RM
    Rev Inst Med Trop Sao Paulo; 1977; 19(5):335-41. PubMed ID: 416483
    [No Abstract]   [Full Text] [Related]  

  • 8. Trypanosoma cruzi: acute and long-term infection in the vertebrate host can modify the response to benznidazole.
    Caldas S; Santos FM; de Lana M; Diniz LF; Machado-Coelho GL; Veloso VM; Bahia MT
    Exp Parasitol; 2008 Mar; 118(3):315-23. PubMed ID: 17945216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trypanosoma cruzi: Induction of benznidazole resistance in vivo and its modulation by in vitro culturing and mice infection.
    Dos Santos FM; Caldas S; de Assis Cáu SB; Crepalde GP; de Lana M; Machado-Coelho GL; Veloso VM; Bahia MT
    Exp Parasitol; 2008 Dec; 120(4):385-90. PubMed ID: 18823980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thioridazine treatment modifies the evolution of Trypanosoma cruzi infection in mice.
    Rivarola HW; Fernández AR; Enders JE; Fretes R; Gea S; Suligoy M; Palma JA; Paglini-Oliva P
    Ann Trop Med Parasitol; 1999 Oct; 93(7):695-702. PubMed ID: 10715697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New process for screening of drugs in experimental infection with Trypanosoma cruzi].
    Campos R; Amato Neto V; de Souza HB; Braz LM
    Rev Inst Med Trop Sao Paulo; 1991; 33(4):325-7. PubMed ID: 1844956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental and preliminary observation on the ultimate influence of cyclosporin on chronic infection of mice by Trypanosoma cruzi].
    Amato Neto V; Moreira AA; Campos R; Duarte MI; Pinto PL; de Sant'Ana EJ
    Rev Hosp Clin Fac Med Sao Paulo; 1986; 41(5):219-21. PubMed ID: 3108993
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of the therapeutic activity of fluconazole in acute experimental infection caused by Trypanosoma cruzi].
    Campos R; Amato Neto V; Moreira AA; de Souza HB; Okumura M; Pinto PL; Braz LM; Silva MF; Matsubara L
    Rev Hosp Clin Fac Med Sao Paulo; 1992; 47(4):174-5. PubMed ID: 1340597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thioridazine treatment prevents cardiopathy in Trypanosoma cruzi infected mice.
    Lo Presti MS; Rivarola HW; Bustamante JM; Fernández AR; Enders JE; Fretes R; Gea S; Paglini-Oliva PA
    Int J Antimicrob Agents; 2004 Jun; 23(6):634-6. PubMed ID: 15194137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trypanosoma cruzi: dehydroepiandrosterone (DHEA) and immune response during the chronic phase of the experimental Chagas' disease.
    Caetano LC; Santello FH; Del Vecchio Filipin M; Brazão V; Caetano LN; Toldo MP; Caldeira JC; do Prado Júnior JC
    Vet Parasitol; 2009 Jul; 163(1-2):27-32. PubMed ID: 19446400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The therapeutic effect of allopurinol on American trypanosomiasis (Chagas disease) in CFW mice].
    Castrillón Rivera LE; García Fernández W; Pérez Gutiérrez C
    Salud Publica Mex; 1984; 26(2):146-54. PubMed ID: 6427943
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic efficacy of several nitroimidazoles for experimental Trypanosoma cruzi infections in mice.
    Malanga CM; Conroy J; Cuckler AC
    J Parasitol; 1981 Feb; 67(1):35-40. PubMed ID: 6785408
    [No Abstract]   [Full Text] [Related]  

  • 18. Trypanocidal activity of 4 isopropyl salicylaldehyde and 4-isopropyl salicylic acid on Trypanosoma cruzi.
    Nogueda-Torres B; Rodríguez-Paez L; Ramírez IB; Ramírez CW
    Rev Latinoam Microbiol; 2001; 43(1):1-6. PubMed ID: 17061565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational drug design in parasitology: trans-sialidase as a case study for Chagas disease.
    Neres J; Bryce RA; Douglas KT
    Drug Discov Today; 2008 Feb; 13(3-4):110-7. PubMed ID: 18275908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunobiological characterization of a presumed atypical strain of Trypanosoma cruzi].
    Muller LA; de Isola EL; Quintana RD; González Cappa SM
    Medicina (B Aires); 1987; 47(2):139-44. PubMed ID: 3121978
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.